Altered dietary salt intake for preventing and treating diabetic kidney disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Suckling, Rebecca J ^a   He, F J ^b   MacGregor, G A ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIETARY INTAKE; DISEASE COURSE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SALT INTAKE;

EID: 44949167671     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006763     Document Type: Review

References (28)

1. Allen 1997 Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 1997;46(1):19-24. [MEDLINE: 8971091].
2. Ames 2001 Ames RP. The effect of sodium supplementation on glucose tolerance and insulin concentrations in patients with hypertension and diabetes mellitus. American Journal of Hypertension 2001;14(7):653-9. [MEDLINE: 11465650].
3. Cianciaruso 1998 Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, et al.Salt intake and renal outcome in patients with progressive renal disease. Mineral & Electrolyte Metabolism 1998;24(4):296-301. [MEDLINE: 9554571].
4. da Costa 1997 da Costa Lima NK, Lima FB, dos Santos EA, Okamoto MM, Matsushita DH, Hell NS, et al.Chronic salt overload increases blood pressure and improves glucose metabolism without changing insulin sensitivity. American Journal of Hypertension 1997;10(7 Pt 1):720-7. [MEDLINE: 9234825].
5. De'Oliveira 1997 De'Oliveira JM, Price DA, Fisher ND, Allan DR, McKnight JA, Williams GH, et al.Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney International 1997;52(3):771-7. [MEDLINE: 9291199].
6. Denton 1995 Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, et al.The effect of increased salt intake on blood pressure of chimpanzees. Nature Medicine 1995;1(10):1009-16. [MEDLINE: 7489355].
7. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91. [MEDLINE: 7718048].
8. Dodson 1889 Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 1989;298(6668) :227-30. [MEDLINE: 2493869].
9. Giunti 2006 Giunti S, Barit D, Cooper M. Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 2006;48(4):519-26. [MEDLINE: 16952978].
10. He 2002 He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. Journal of Human Hypertension 2002;16(11):761-70. [MEDLINE: 12444537].
11. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120].
12. Hillege 2002 Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al.Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106(14):1777-82. [MEDLINE: 12356629].
13. Houlihan 2002 Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 2002;25(6):1072-7. [MEDLINE: 12032117].
14. Hu 2005 Hu G, Jousilahti P, Peltonen M, Lindstrom J, Tuomilehto J. Urinary sodium and potassium excretion and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 2005;48(8):1477-83. [MEDLINE: 15971060].
15. Intersalt 1988 Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297(6644):319-28. [MEDLINE: 3416162].
16. Lefebvre 1996 Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia). 1996.
17. Lifton 1996 Lifton RP. Molecular genetics of human blood pressure variation. Science 1996;272(5262):676-80. [MEDLINE: 8614826].
18. MacGregor 1987 MacGregor G, Markandu ND, Singer DR, Cappuccio FP, Shore AC, Sagnella GA. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. British Medical Journal Clinical Research Ed 1987;294(6571):531-4. [MEDLINE: 3103761].
19. Master List 2007 United States Cochrane Center. Master list of journals being searched. http://apps1.jhsph.edu/cochrane/masterlist.asp (accessed July 2007).
20. Price 1999 Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. American Journal of Hypertension 1999;12(4Pt 1):348-55. [MEDLINE: 10232494].
21. Schrier 2002 Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International 2002;61(3):1086-97. [MEDLINE: 11849464].
22. Sharma 1997 Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, et al.Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 1997;46(5):854-9. [MEDLINE: 9133555].
23. Swift 2005 Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005;46(2):308-12. [MEDLINE: 15983240].
24. Trujillo 1989 Trujillo A, Eggena P, Barrett J, Tuck M. Renin regulation in type II diabetes mellitus: influence of dietary sodium. Hypertension 1989;13(3):200-5. [MEDLINE: 2646216].
25. Vedovato 2004 Vedovato M, Lepore G, Coracina A, Dodesini AR, Jori E, Tiengo A, et al.Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia 2004;47(2):300-3. [MEDLINE: 14704836].
26. Ying 1998a Ying WZ, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta1. American Journal Physiology 1998;275(1 Pt 2):F18-24. [MEDLINE: 9689000].
27. Ying 1998b Ying WZ, Sanders PW. Dietary salt modulates renal production of transforming growth factor-beta in rats. American Journal Physiology 1998;274(4 Pt 2):F635-41. [MEDLINE: 9575885].
28. Yu 1998 Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, et al.Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998;98(23):2621-8. [MEDLINE: 9843472].